Optimi Health (8BN0) AI Stock Analysis

Optimi Health

(Frankfurt:8BN0)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Equity CushionThe sizeable equity base relative to assets provides some balance-sheet cushioning and indicates the company is not currently described as asset-distressed. This support may help preserve operating flexibility while management works to improve profitability and cash generation.

Negative Factors

Persistent Unprofitable OperationsThe combination of very low and declining revenue with a substantial net loss shows that the business has not yet reached an economically sustainable operating scale. Persistent losses can limit reinvestment capacity and make future improvement dependent on a successful turnaround.

Optimi Health (8BN0) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 20.61M
Dividend Yield: ―
Average Volume (3M): 325
Price to Earnings (P/E): -1.8
Beta (1Y): -0.18
Revenue Growth: ―
EPS Growth: ―
Country: Germany
Employees: 9
Sector: Healthcare
Sector Strength: 51
Industry: Drug Manufacturers - Specialty & Generic

Optimi Health Business Overview & Revenue Model

Company Description

Optimi Health Corp. focuses on developing an integrated brand of functional mushrooms specifically for the Canadian health and wellness food markets. The company manages the entire process from the cultivation and extraction to the processing and dis...

Optimi Health Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

DE:8BN0 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
TSE:LABS	49Neutral	CAD 27.77M	-5.60	-13.79%	―	-6.74%	43.54%
TSE:ROMJ	45Neutral	CAD 25.34M	-15.24	-4.00%	―	16.66%	-1007.41%
TSE:AVCN	41Neutral	CAD 14.11M	-3.24	-108.44%	―	-0.23%	-142.54%
TSE:DOSE	38Underperform	CAD 14.33M	-4.41	46.54%	―	4.30%	38.28%
TSE:PCLO	24Underperform	CAD 9.34M	-2.67	28.59%	―	0.90%	57.73%

* Healthcare Sector Average

Performance Comparison

DE:8BN0 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:8BN0	Optimi Health Corp.	2.01	-4.17	-67.48%
TSE:DOSE	Rapid Dose Therapeutics Corp	0.10	-0.06	-34.38%
TSE:LABS	Medipharm Labs (Otc)	0.07	-0.01	-13.33%
TSE:PCLO	Pharmacielo	0.05	0.01	11.11%
TSE:ROMJ	Rubicon Organics	0.38	-0.13	-25.00%
TSE:AVCN	Avicanna Inc	0.10	-0.16	-60.38%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Optimi Health AI Stock Analysis